All In MedTech

FDA Clearance Tracker · P850010-S019

HELISTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 20, 2006 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 20, 2006

Approved

Time to decision

355 days

Received Sep 30, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P850010-S019
Device name
HELISTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTS
Applicant location
Plainsboro, NJ
Received
Sep 30, 2005
Decided
Sep 20, 2006
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P850010

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT INTEGRA NEUROSCIENCES PR, INC., ANASCO, PUERTO RICO FOR PACKAGING AND STERI-TECH, INC., SALINAS, PUERTO RICO FOR STERILIZATION.

Source documents

Other decisions for Integra LifeSciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.